Twin Trial of PDE4 Inhibition With Roflumilast for the Management of Plaque Psoriasis
Public ClinicalTrials.gov record NCT04211389. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, 8-Week, Parallel Group, Double Blind, Vehicle-Controlled Study of the Safety and Efficacy of ARQ-151 Cream 0.3% Administered QD in Subjects With Chronic Plaque Psoriasis
Study identification
- NCT ID
- NCT04211389
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Arcutis Biotherapeutics, Inc.
- Industry
- Enrollment
- 442 participants
Conditions and interventions
Conditions
Interventions
- ARQ-151 0.3% cream Drug
- ARQ-151 vehicle cream Drug
Drug
Eligibility (public fields only)
- Age range
- 2 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 16, 2019
- Primary completion
- Nov 22, 2020
- Completion
- Nov 22, 2020
- Last update posted
- Dec 6, 2022
2019 – 2020
United States locations
- U.S. sites
- 31
- U.S. states
- 17
- U.S. cities
- 29
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Arcutis Biotherapeutics Clinical Site 203 | Scottsdale | Arizona | 85255 | — |
| Arcutis Biotherapeutics Clinical Site 239 | Beverly Hills | California | 90212 | — |
| Arcutis Biotherapeutics Clinical Site 225 | Encino | California | 91436 | — |
| Arcutis Biotherapeutics Clinical Site 220 | San Diego | California | 92123 | — |
| Arcutis Biotherapeutics Clinical Site 208 | Santa Monica | California | 90404 | — |
| Arcutis Biotherapeutics Clinical Site 215 | Santa Monica | California | 90503 | — |
| Arcutis Biotherapeutics Clinical Site 223 | Boynton Beach | Florida | 91436 | — |
| Arcutis Biotherapeutics Clinical Site 237 | DeLand | Florida | 32720 | — |
| Arcutis Biotherapeutics Clinical Site 228 | Largo | Florida | 33770 | — |
| Arcutis Biotherapeutics Clinical Site 201 | North Miami Beach | Florida | 33162 | — |
| Arcutis Biotherapeutics Clinical Site 209 | Sweetwater | Florida | 33172 | — |
| Arcutis Biotherapeutics Clinical Site 214 | Indianapolis | Indiana | 46250 | — |
| Arcutis Biotherapeutics Clinical Site 217 | Louisville | Kentucky | 40217 | — |
| Arcutis Biotherapeutics Clinical Site 211 | Lake Charles | Louisiana | 70605 | — |
| Arcutis Biotherapeutics Clinical Site 213 | Metairie | Louisiana | 70006 | — |
| Arcutis Biotherapeutics Clinical Site 224 | New Orleans | Louisiana | 70115 | — |
| Arcutis Biotherapeutics Clinical Site 212 | Detroit | Michigan | 48202 | — |
| Arcutis Biotherapeutics Clinical Site 216 | Fridley | Minnesota | 55432 | — |
| Arcutis Biotherapeutics Clinical Site 227 | Saint Joseph | Missouri | 64506 | — |
| Arcutis Biotherapeutics Clinical Site 219 | Las Vegas | Nevada | 89148 | — |
| Arcutis Biotherapeutics Clinical Site 231 | Las Vegas | Nevada | 89148 | — |
| Arcutis Biotherapeutics Clinical Site 240 | Reno | Nevada | 89703 | — |
| Arcutis Biotherapeutics Clinical Site 236 | Portsmouth | New Hampshire | 03801 | — |
| Arcutis Biotherapeutics Clinical Site 222 | Oklahoma City | Oklahoma | 73112 | — |
| Arcutis Biotherapeutics Clinical Site 229 | Broomall | Pennsylvania | 19008 | — |
| Arcutis Biotherapeutics Clinical Site 233 | Knoxville | Tennessee | 37922 | — |
| Arcutis Biotherapeutics Clinical Site 221 | Murfreesboro | Tennessee | 37130 | — |
| Arcutis Biotherapeutics Clinical Site 206 | Arlington | Texas | 76011 | — |
| Arcutis Biotherapeutics Clinical Site 238 | Houston | Texas | 77030 | — |
| Arcutis Biotherapeutics Clinical Site 210 | West Jordan | Utah | 84088 | — |
| Arcutis Biotherapeutics Clinical Site 230 | Richmond | Virginia | 23220 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 8 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04211389, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 6, 2022 · Synced May 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04211389 live on ClinicalTrials.gov.